|
Consolidated Statements of Operations (USD $)
In Millions, except Share data in Thousands, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Revenue | $ 19,615.6us-gaap_Revenues | $ 23,113.1us-gaap_Revenues | $ 22,603.4us-gaap_Revenues |
| Cost of sales | 4,932.5us-gaap_CostOfGoodsSold | 4,908.1us-gaap_CostOfGoodsSold | 4,796.5us-gaap_CostOfGoodsSold |
| Research and development | 4,733.6us-gaap_ResearchAndDevelopmentExpense | 5,531.3us-gaap_ResearchAndDevelopmentExpense | 5,278.1us-gaap_ResearchAndDevelopmentExpense |
| Marketing, selling, and administrative | 6,620.8us-gaap_SellingGeneralAndAdministrativeExpense | 7,125.6us-gaap_SellingGeneralAndAdministrativeExpense | 7,513.5us-gaap_SellingGeneralAndAdministrativeExpense |
| Acquired in-process research and development | 200.2lly_AcquiredInProcessResearchAndDevelopment | 57.1lly_AcquiredInProcessResearchAndDevelopment | 0lly_AcquiredInProcessResearchAndDevelopment |
| Asset impairment, restructuring, and other special charges | 468.7us-gaap_RestructuringSettlementAndImpairmentProvisions | 120.6us-gaap_RestructuringSettlementAndImpairmentProvisions | 281.1us-gaap_RestructuringSettlementAndImpairmentProvisions |
| Other-net, (income) expense | 340.5us-gaap_NonoperatingIncomeExpense | 518.9us-gaap_NonoperatingIncomeExpense | 674.0us-gaap_NonoperatingIncomeExpense |
| Cost of sales, operating expenses, and other-net | 16,615.3lly_CostOfSalesOperatingExpensesAndOtherNet | 17,223.8lly_CostOfSalesOperatingExpensesAndOtherNet | 17,195.2lly_CostOfSalesOperatingExpensesAndOtherNet |
| Income before income taxes | 3,000.3us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | 5,889.3us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | 5,408.2us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments |
| Income taxes | 609.8us-gaap_IncomeTaxExpenseBenefit | 1,204.5us-gaap_IncomeTaxExpenseBenefit | 1,319.6us-gaap_IncomeTaxExpenseBenefit |
| Net income | $ 2,390.5us-gaap_NetIncomeLoss | $ 4,684.8us-gaap_NetIncomeLoss | $ 4,088.6us-gaap_NetIncomeLoss |
| Weighted-average number of common shares oustanding, including incremental shares | 1,069,932us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 1,080,874us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 1,113,178us-gaap_WeightedAverageNumberOfSharesOutstandingBasic |
| Basic earnings per share | $ 2.23us-gaap_EarningsPerShareBasic | $ 4.33us-gaap_EarningsPerShareBasic | $ 3.67us-gaap_EarningsPerShareBasic |
| Weighted-average number of common shares oustanding, including incremental shares and stock options | 1,074,286us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 1,084,766us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 1,117,294us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted earnings per share | $ 2.23us-gaap_EarningsPerShareDiluted | $ 4.32us-gaap_EarningsPerShareDiluted | $ 3.66us-gaap_EarningsPerShareDiluted |
| X | ||||||||||
|
- Definition
The amount of EXPENSE related to research and development assets that are acquired in a business combination (pre-141R) and/or licensing arrangement that have no alternative future use and are therefore written off in the period of acquisition (INCOME STATEMENT) No definition available.
|
| X | ||||||||||
|
- Definition
Cost of sales, operating expenses, and other-net No definition available.
|
| X | ||||||||||
|
- Definition
Total costs related to goods produced and sold during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate amount provided for estimated restructuring charges, remediation costs, and asset impairment loss during an accounting period. Generally, these items are either unusual or infrequent, but not both (in which case they would be extraordinary items). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|